Is Healthy Life overvalued or undervalued?

As of 24 October 2025, the valuation grade for Healthy Life has moved from attractive to very attractive, indicating a significant improvement in its perceived value. The company is currently considered undervalued, particularly in comparison to its peers. Key ratios include a PE ratio of 27.10, an EV to EBITDA of 18.01, and a ROCE of 13.87%.
In the peer comparison, Healthy Life's PE ratio is notably lower than that of Hindustan Unilever, which stands at 55.92, and Nestle India, which has a PE of 82.53, both categorized as very expensive. This suggests that Healthy Life offers a more favorable valuation relative to its competitors in the FMCG sector. Additionally, while Healthy Life has experienced a significant decline in stock price year-to-date, it has outperformed the Sensex over the past three years with a return of 339.42%, reinforcing its undervalued status in the current market.